Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens
AADAC Polyclonal Antibody. Unconjugated. Raised in: Rabbit.
Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Human, Mouse, Rat
Recombinant fusion protein containing a sequence corresponding to amino acids 170-399 of human AADAC (NP_001077.2).
Shipped at 4°C. Upon receipt, store at -20°C. Avoid freeze / thaw cycles
AADAC; CES5A1; DAC; arylacetamide deacetylase
WB, IHC; Recommended dilution: WB 1:500 - 1:2000, IHC 1:50 - 1:100